Form 4: Medtronic Director Randall J. Hogan, III, Reports Stock Transactions

Randall J. Hogan, III, a director at Medtronic plc, reported the acquisition and disposal of ordinary shares, including the vesting of restricted stock units and shares withheld for tax payments.

Summary

• On April 28, 2025, Medtronic director Randall J. Hogan, III, acquired 2,083 ordinary shares at $84.04 per share through the vesting of restricted stock units.
• Following this transaction, Hogan directly owned 47,245 ordinary shares.
• On April 29, 2025, Hogan disposed of 216 ordinary shares at $84.60 per share to cover tax obligations related to the vesting of restricted stock units.
• After this disposal, Hogan directly owned 47,029 ordinary shares.
• Hogan has granted power of attorney to several individuals to handle SEC filings on his behalf.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies like Medtronic, similar to filings made by insiders at companies such as Johnson & Johnson, Abbott Laboratories, and Boston Scientific.
• The transactions reported are typical for executives receiving stock-based compensation and managing their tax obligations.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine insider trading activity.

Key Dates

Keywords

Medtronic, Director, Stock Transactions, Form 4, SEC Filing, Ordinary Shares, Restricted Stock Units, Power of Attorney